02 April 2024
02 April 2024
The company will focus its resources on clinical development plans for two Phase I candidates, including an asset licenced to Gilead.
The Clinical Trials Arena team also evaluates candidates in oncology and ophthalmology.
The trials for orforglipron involve a total of 120 participants located across 12 sites in India.
Fasedienol is a rapid-onset investigational pherine nasal spray and is intended for the acute treatment of SAD.
To fulfil their potential, decentralised clinical trials must adopt a patient-centric approach to ensure data accuracy. Using the right translation and accessibility tools can facilitate patient comprehension and avoid costly delays.
The GARDian study will evaluate the efficacy of OCU410ST when administered subretinally to individuals with Stargardt disease.
The trial will compare a 45mg once-daily oral dose of inaxaplin to a placebo, in addition to standard of care.
The Casppian study aims to evaluate the 42mg-controlled release FP-001 in patients with central precocious puberty.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
